| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.59 | 0.08 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.31 | 0.04 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.19 | 0.0009 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |